Autolus Therapeutics plc (AUTL)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.49
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.41
P/B Ratio
3.64
Institutional Ownership
46.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 33.62M | $46.0M | 12.63% | +3.62M | 2026-03-31 |
| Blackstone Inc. | 20.49M | $28.0M | 7.70% | -- | 2026-03-31 |
| Syncona Portfolio Ltd | 16.64M | $22.0M | 6.25% | -- | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 15.80M | $21.0M | 5.94% | -1.70M | 2026-03-31 |
| TFG Asset Management GP Ltd | 9.50M | $13.0M | 3.57% | -- | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 4.45M | $6.0M | 1.67% | -175.4K | 2026-03-31 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3.36M | $4.0M | 1.26% | -- | 2026-03-31 |
| Laurion Capital Management LP | 3.32M | $4.0M | 1.25% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 2.30M | $3.0M | 0.86% | -805.9K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 1.84M | $2.0M | 0.69% | -116.1K | 2026-03-31 |